ST6GAL1 similarly promoted tumor growth in the S2-LM7AA cell model, evidenced by the reduced growth of pancreatic tumors (Figure 1, I and J) and decreased liver metastasis (Figure 1K) in the KD cohort compared with shC controls. Here, ST6GAL1 is linked to neoplasm.